Publications

Search our bibliography using the filters on the right-hand side.

Displaying 351 through 400 of 540 publications.

Real FG, Svanes C, Omenaas ER, Anto JM, Plana E, Janson C. Menstrual irregularity and asthma and lung function. J Allergy Clin Immunol. 2007 Sep;120(3):557-64.

Lynch NO, Earnshaw SR, Graham CN, Patroe V, Boisdron J, Middelhoven H. Ibandronate IV injection is cost-effective in the treatment of UK women with postmenopausal osteoporosis who are intolerant to oral bisphosphonates. Poster presented at the European League Against Rheumatism (EULAR) 2007 Annual European Congress of Rheumatology; June 2007.

Havrilesky LJ, Secord AA, Bae-Jump V, Ayeni T, Calingaert B, Clarke-Pearson DL, Berchuck A, Gehrig PA. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007 Jun 1;105(3):677-82.

Shadoan MK, Kavanagh K, Zhang L, Anthony MS, Wagner JD. Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue. Metabolism. 2007 Jun;56(6):830-7.

Mahon BE, Ehrenstein V, Norgaard M, Pedersen L, Rothman KJ, Sorensen HT. Perinatal risk factors for hospitalization for pneumococcal disease in childhood: a population-based cohort study. Pediatrics. 2007 Apr 1;119(4):e804-12.

Ehrenstein V, Pedersen L, Holsteen V, Larsen H, Rothman KJ, Sorensen HT. Postterm delivery and risk of epilepsy in childhood. Pediatrics. 2007 Mar 30;119(3):e554-61.

Lynch NO, Earnshaw SR, Graham CN, Middelhoven H. Cost-effectiveness of ibandronate injection IV in the treatment of UK women with postmenopausal osteoporosis who are intolerant to oral bisphosphonates. Poster presented at the Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO); March 2007.

Navarro P, Garcia-Esteve LL, Ascaso C, Aguado J, Martin-Santos R. Prevalence of postnatal psychiatric morbidity: a preliminary analysis. Poster presented at the 15th AEP Congress; March 2007. Madrid, Spain. [abstract] Eur Psychiatry. 2007 Mar; 22(Suppl 1):S328-9. doi: 10.1016/j.eurpsy.2007.01.1095

Anthony MS. Soy and women's health. Nutrition for health: an evidence based approach through diet and supplements. Presented at the University of California Irvine; February 25, 2007. Newport Beach, CA.

Pignone M, Earnshaw S, Pletcher MJ, Tice JA. Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. Arch Intern Med. 2007 Feb 12;167(3):290-5.

Tennis P, Andrews E, Hickman P, Miller D, Hollis KA, Cook S. The relationship between dosing of alosetron and discontinuation patterns reported by patients participating in a follow-up programme. Aliment Pharmacol Ther. 2007 Feb 1;25(3):317-22.

Havrilesky LJ, Cragun JM, Calingaert B, Secord AA, Valea FA, Clarke-Pearson DL, Berchuck A, Soper JT. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol. 2007 Feb 1;104(2):401-5.

Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Antidepressant-induced sexual dysfunction in three European countries: prevalence and impact in a cross-sectional survey replication. J Psychopharmacol. 2007;21(Suppl):A39.

Navarro P, Ascaso C, Garcia-Esteve L, Aguado J, Torres A, Martín-Santos R. Postnatal psychiatric morbidity: a validation study of the GHQ-12 and the EPDS as screening tools. General Hospital Psychiatry. 2007 Jan;29(1):1-7.

Garcia-Esteve L, Navarro P, Ascaso C, Aguado J, Torres A. Major depressive episode in postpartum: a preliminary prospective 1-year naturalistic follow-up. In: Colombus F, editors. New research on postpartum depression. New York: United States. Novs Science Publishers, Inc; 2007. p.85-104.

Seeger JD, West WA, Fernandez C, Rivero E. Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology. 2006 Dec 1;214(1):32-9.

Earnshaw SR, Graham CN, Amonkar MM, Poston SA, Barr CE. Cost-effectiveness of ibandronate intravenous injection in the treatment of US women with postmenopausal osteoporosis. Poster presented at the 2006 American College of Rheumatology Scientific Meeting; November 2006.

Maxwell GL, Schildkraut JM, Calingaert B, Risinger JI, Dainty L, Marchbanks PA, Berchuck A, Barrett JC, Rodriguez GC. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk. Gynecol Oncol. 2006 Nov 1;103(2):535-40.

Mathews R, Leiss J, Vanderpuije A. Completion of high school among teenage mothers in North Carolina: a prospective study using maternally linked birth records. Poster presented at the 134th Annual Meeting of the American Public Health Association; November 2006.

Mast TC, DeMuro-Mercon CJ, HPV Psychosocial Team. Describing the psychosocial burden of illness among women experiencing human papillomavirus-related illness or screening interventions. Poster presented at the 18th World Congress of the International Federation of Gynecology and Obstetrics; November 2006.

Williams RE, DiBenedetti D, Zhou X, Fehnel SE, Clark RV. Healthcare seeking behavior among peri- and post-menopausal women: results from the US population-based mepi study. Poster presented at the 17th Annual Meeting of The North American Menopause Society; October 14, 2006.

Williams RE, DiBenedetti D, Zhou X, Fehnel SE, Clark RV. The menopause epidemiology (MEPI) study: vasomotor symptom results from a large population-based study. Poster presented at the 17th Annual Meeting of The North American Menopause Society; October 14, 2006.

Levine KB, Williams RE, DiBenedetti DB, Fehnel SE, Clark RV. Vulvo-Vaginal atrophy and female sexual dysfunction among post-menopausal women: results from the MEPI study. Poster presented at 17th Annual Meeting of the North American Menopause Society; October 2006. Nashville, TN. [abstract] Menopause. 2006 Oct 1; 13(6):990.

Appt SE, Clarkson TB, Lees CJ, Anthony MS. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys. Maturitas. 2006 Sep 20;55(2):187-94.

Earnshaw SR, Beard SM, Lynch NO, Cooper A, Cowell W, Middelhoven H. A comparison of the cost-effectiveness of bisphosphonates using persistence data from a UK propsective rct. Poster presented at the 28th Annual Meeting of the American Society for Bone and Mineral Research; September 19, 2006.

Williams VSL, Jones G, Mauskopf J, Spalding J, Duchane J. Uterine fibroids: a review of health-related quality of life assessment. J Womens Health. 2006 Sep 7;15(7):818-29.

Arana A, Varas C, Gonzalez-Perez A, Gutierrez L, Bjerrum L, Garcia Rodriguez LA. Hormonal therapy and cerebrovascular events: a population-based nested case-control study. Menopause. 2006 Sep 1;13(5):730-6.

Sanchez Matienzo D, Lanza LL, McQuay L, Gutierrez L, Arana Navarro A, Perez-Gutthann S. Descriptive study of users of depo-medroxyprogesterone acetate (DMPA) in the mhra gprd. Presented at the 22nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2006. Lisbon, Portugal.

Seeger JD, Quinn S, Lievano F, Rivero E, Earnest DL, Shetzline M, Holden W, Walker AM. No increased risk of abdominal or pelvic surgery associated with tegaserod exposure: the zelnormTM epidemiological study. Presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management,; August 2006. Lisbon, Portugal. [abstract] Pharmacoepidemiol Drug Saf. 2006 Aug; 15(Suppl 1):S12-3.

Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol. 2006 Jul 1;102(1):92-7.

Foreman J, Martin G, Roberts JE, Moskowitz L, Harris A, Nelson LM. Initiations in the discourse of boys with fragile x syndrome and down syndrome. Poster presented at the International Fragile X Conference; July 2006.

Martin GE, Roberts JE, Moskowitz L, Harris A, Foreman J, Nelson LM. Discourse skills of boys with fragile x syndrome in comparison to boys with down syndrome. Poster presented at the International Fragile X Conference; July 2006.

Earnshaw SR, Beard SM, Lynch NO, Cowell W. Ibandronate in the treatment of postmenopausal osteoporosis: a cost-effectiveness analysis in the UK. Poster presented at the European League Against Rheumatism Annual European Congress of Rheumatology; June 24, 2006.

Moreland S, Talbird SE. Achieving the Millennium Development Goals: the contribution of fulfilling the unmet need for family planning. 2006.

Earnshaw SR, Graham CN, Amonkar MM, Barr CE. The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US. Value Health. 2006 May 1;9(3):A163.

Earnshaw SR, Graham CN, Amonkar MM, Barr C. The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US. Poster presented at the 2006 ISPOR 11th Annual International Meeting; May 20, 2006. Philadelphia, PA. [abstract] Value Health. 2006 May; 9(3):A163.

Williams VSL, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry. 2006 Feb 1;67(2):204-10.

Wood CE, Register TC, Franke AA, Anthony MS, Cline JM. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res. 2006 Jan 15;66(2):1241-9.

Langagergaard V, Gislum M, Skriver MV, Norgard B, Lash TL, Rothman KJ, Sorensen HT. Birth outcome in women with breast cancer. Br J Cancer. 2006 Jan 1;94(1):142-6.

Havrilesky LJ, Cragun JM, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL, Berchuck A. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol. 2005 Dec 1;99(3):689-95.

Sorensen HT, Pedersen L, Norgaard M, Wogelius P, Rothman KJ. Maternal asthma, preeclampsia and risk of hypospadias. Epidemiology. 2005 Nov 1;16(6):806-7.

Britt DM, Fehnel SE, Granger AL, Zhou X, Williams R. Quality of life and the prevalence of vasomotor symptoms in a population-based sample of peri- and post-menopausal women. Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 19, 2005. San Francisco, CA.

Pignone M, Earnshaw SR. Cost-effectiveness of aspirin for the primary prevention of cardiovascular events in women. Poster presented at the Society of Medical Decision Making; October 2005.

Hoyo C, Berchuck A, Halabi S, Bentley RC, Moorman P, Calingaert B, Schildkraut JM. Anthropometric measurements and epithelial ovarian cancer risk in african–american and white women. Cancer Causes Control. 2005 Oct 1;16(8):955-63.

Ettinger B, Earnshaw SR, Graham CN, Amonkar MM, Baran RW. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with ibandronate. Poster presented at the American Society for Bone and Mineral Research (ASBMR) 27th Annual Meeting; September 2005.

Anthony MS, Bradbury BD, Satia JA. Diagnosed osteoporosis: the tip of the iceberg. Poster presented at the 27th Annual Meeting of the American Society for Bone and Mineral Research; August 2005. [abstract] J Bone Miner Res. 2005 Aug 11; 20(Suppl 1):S261.

Sunyer J, Anto JM, Plana E, Janson C, Jarvis D, Kony S. Maternal atopy and changes in parity. Clin Exp Allergy. 2005 Aug;35(8):1028-32.

Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause. 2005 Jul 1;12(4):385-98.

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Berchuck A. Menopausal hormones and risk of ovarian cancer. Am J Obstet Gynecol. 2005 Jul 1;193(1):75-82.

Garcia-Esteve L, Torres A, Navarro P, Aguado J, Ascaso C. Maternidad the planned y psicomorbilidad: un riesgo evitable / Unplanned pregnancy and psychological morbidity: an avoidable risk. Fac Med Barc. 2005 Jul;32(3):111-8.